Literature DB >> 11710941

Protein tyrosine phosphatase genes downregulated in melanoma.

L McArdle1, M Rafferty, G M Maelandsmo, O Bergin, C J Farr, P A Dervan, S O'Loughlin, M Herlyn, D J Easty.   

Abstract

Phospho-tyrosine levels are increased in melanoma, apparently consistent with reports of elevated protein tyrosine kinase activity. Some protein tyrosine kinases are encoded by oncogenes and have been implicated in melanoma genesis. Decreased protein tyrosine phosphatase activity may also increase phospho-tyrosine. Protein tyrosine phosphatase genes are candidate tumor suppressors and loss of expression may contribute to melanoma genesis. Here we survey protein tyrosine phosphatase expression in pigment cells. Protein tyrosine phosphatase genes were cloned by reverse transcriptase polymerase chain reaction using degenerate primers based upon conserved sequences within the phosphatase catalytic domain. Reaction products were cloned and sequenced: 118 and 113 partial protein tyrosine phosphatase products were isolated from normal melanocytes and melanoma cells, respectively. Northern blotting analysis was used to study expression of 15 protein tyrosine phosphatase genes. Expression of PTP-kappa and PTP-pi was absent or downregulated in more than 20% of melanoma cell lines and in some unmanipulated melanoma biopsies. These closely related enzymes are members of the 2B receptor protein tyrosine phosphatase family previously implicated in contact inhibition. Loss of protein tyrosine phosphatase expression may contribute to the abnormal tyrosine phosphorylation seen in melanoma; these genes are candidate tumor suppressors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11710941     DOI: 10.1046/j.0022-202x.2001.01534.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  17 in total

Review 1.  Tumour suppressor function of protein tyrosine phosphatase receptor-T.

Authors:  Anthony Scott; Zhenghe Wang
Journal:  Biosci Rep       Date:  2011-10       Impact factor: 3.840

2.  Cancer-derived mutations in the fibronectin III repeats of PTPRT/PTPrho inhibit cell-cell aggregation.

Authors:  Peng Zhang; Scott Becka; Sonya E L Craig; David T Lodowski; Susann M Brady-Kalnay; Zhenghe Wang
Journal:  Cell Commun Adhes       Date:  2009-12

Review 3.  Role of protein tyrosine phosphatases in cancer.

Authors:  Tasneem Motiwala; Samson T Jacob
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

4.  Characterization of the adhesive properties of the type IIb subfamily receptor protein tyrosine phosphatases.

Authors:  Scott Becka; Peng Zhang; Sonya E L Craig; David T Lodowski; Zhenghe Wang; Susann M Brady-Kalnay
Journal:  Cell Commun Adhes       Date:  2010-04

Review 5.  Plasma membrane proteomics and its application in clinical cancer biomarker discovery.

Authors:  Rikke Leth-Larsen; Rikke R Lund; Henrik J Ditzel
Journal:  Mol Cell Proteomics       Date:  2010-04-08       Impact factor: 5.911

Review 6.  Tumor-derived extracellular fragments of receptor protein tyrosine phosphatases (RPTPs) as cancer molecular diagnostic tools.

Authors:  Sonya E L Craig; Susann M Brady-Kalnay
Journal:  Anticancer Agents Med Chem       Date:  2011-01       Impact factor: 2.505

Review 7.  Inside the human cancer tyrosine phosphatome.

Authors:  Sofi G Julien; Nadia Dubé; Serge Hardy; Michel L Tremblay
Journal:  Nat Rev Cancer       Date:  2011-01       Impact factor: 60.716

8.  Clinical study of noninvasive in vivo melanoma and nonmelanoma skin cancers using multimodal spectral diagnosis.

Authors:  Liang Lim; Brandon Nichols; Michael R Migden; Narasimhan Rajaram; Jason S Reichenberg; Mia K Markey; Merrick I Ross; James W Tunnell
Journal:  J Biomed Opt       Date:  2014       Impact factor: 3.170

9.  A deletion mutation of the protein tyrosine phosphatase kappa (Ptprk) gene is responsible for T-helper immunodeficiency (thid) in the LEC rat.

Authors:  Atsushi Asano; Kouta Tsubomatsu; Cha-Gyun Jung; Nobuya Sasaki; Takashi Agui
Journal:  Mamm Genome       Date:  2007-10-02       Impact factor: 2.957

Review 10.  Regulation of development and cancer by the R2B subfamily of RPTPs and the implications of proteolysis.

Authors:  Sonya E L Craig; Susann M Brady-Kalnay
Journal:  Semin Cell Dev Biol       Date:  2014-09-16       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.